Si-Bone (SIBN) Net Income towards Common Stockholders (2017 - 2026)

Si-Bone's (SIBN) quarterly Net Income towards Common Stockholders came in at -$18.4 million in Q1 2026, down 180.81% year-on-year from $22.8 million in Q1 2025, and down 1017.44% quarter-over-quarter from -$1.6 million in Q4 2025.

Si-Bone (SIBN) Net Income towards Common Stockholders (2017 - 2026) Analysis & Trends

Si-Bone's Net Income towards Common Stockholders history runs 10 years deep, the most recent figure standing at -$18.4 million for Q1 2026.

  • On a quarterly basis, Net Income towards Common Stockholders fell 180.81% year-over-year to -$18.4 million in Q1 2026; TTM through Mar 2026 was -$5.4 billion, a 19199.97% decrease from a year earlier, with the FY2025 full-year figure at -$127.4 million, up 9.39% from the prior year.
  • Net Income towards Common Stockholders slipped to -$18.4 million in Q1 2026 per SIBN's latest filing, from -$1.6 million in the prior quarter.
  • Across five years, Net Income towards Common Stockholders topped out at -$1.6 million in Q4 2025 and bottomed at -$5.4 billion in Q3 2025.
  • The 5-year median for Net Income towards Common Stockholders is -$11.2 million (2023), against an average of -$326.0 million.
  • Biggest YoY gain for Net Income towards Common Stockholders was 72.03% in 2025; the steepest drop was 81390.17% in 2025.
  • Year by year, Net Income towards Common Stockholders stood at -$12.2 million in 2022, then declined by 1.17% to -$12.3 million in 2023, then soared by 52.17% to -$5.9 million in 2024, then surged by 72.03% to -$1.6 million in 2025, then tumbled by 1017.44% to -$18.4 million in 2026.
  • Per Business Quant, the three latest SIBN Net Income towards Common Stockholders figures stand at -$18.4 million (Q1 2026), -$1.6 million (Q4 2025), and -$5.4 billion (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Abbott Laboratories 182.32 Bn 175.02 Bn 6.27 Bn 1.08 Bn
2 Stryker 128.75 Bn 125.88 Bn 3.81 Bn 745.00 Mn
3 Medtronic 107.83 Bn 98.61 Bn 6.41 Bn 1.26 Bn
4 Boston Scientific 67.61 Bn 66.15 Bn 3.61 Bn 1.34 Bn
5 Edwards Lifesciences 48.13 Bn 44.45 Bn 1.29 Bn -
6 Dexcom 28.26 Bn 27.14 Bn 750.30 Mn 199.50 Mn
7 GE HealthCare Technologies 27.78 Bn 25.50 Bn 1.98 Bn 411.00 Mn
8 Smith & Nephew 26.99 Bn 26.41 Bn - -
9 Koninklijke Philips 23.92 Bn 20.80 Bn 2.07 Bn 176.78 Mn
10 Si-Bone 753.03 Mn 608.35 Mn 41.94 Mn -18.39 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -18.39 Mn
Dec 31, 2025 -1.65 Mn
Sep 30, 2025 -5.36 Bn
Jun 30, 2025 -13.17 Mn
Mar 31, 2025 -6.55 Mn
Dec 31, 2024 -5.89 Mn
Sep 30, 2024 -6.58 Mn
Jun 30, 2024 -8.94 Mn
Mar 31, 2024 -10.81 Mn
Dec 31, 2023 -12.31 Mn
Sep 30, 2023 -9.88 Mn
Jun 30, 2023 -11.23 Mn
Mar 31, 2023 -11.20 Mn
Dec 31, 2022 -12.16 Mn
Sep 30, 2022 -13.98 Mn
Jun 30, 2022 -18.37 Mn
Mar 31, 2022 -17.36 Mn
Dec 31, 2021 -18.43 Mn
Sep 30, 2021 -15.81 Mn
Jun 30, 2021 -13.99 Mn